This HTML5 document contains 37 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/drugbank/drug/DB03309/identifier/pubchem-substance/
n13http://linked.opendata.cz/resource/drugbank/drug/DB03309/identifier/drugbank/
n8http://linked.opendata.cz/resource/mesh/concept/
n4http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n9http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/ontology/drugbank/
n7http://linked.opendata.cz/ontology/mesh/
owlhttp://www.w3.org/2002/07/owl#
n6http://linked.opendata.cz/resource/drugbank/property/
n14http://linked.opendata.cz/resource/drugbank/drug/DB03309/identifier/pdb/
xsdhhttp://www.w3.org/2001/XMLSchema#
n11http://linked.opendata.cz/resource/drugbank/drug/DB03309/identifier/pubchem-compound/

Statements

Subject Item
n2:DB03309
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n4:DB03309 n9:DB03309
dcterms:title
N-Cyclohexyltaurine
adms:identifier
n11:66898 n12:46506550 n13:DB03309 n14:NHE
n5:synonym
CHES
n7:hasConcept
n8:M0145180
n5:IUPAC-Name
n6:271B6355-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B635B-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B635A-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B6357-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B6358-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B6359-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B6353-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B6351-363D-11E5-9242-09173F13E4C5 n6:271B6354-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B6352-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B6361-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B6362-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B635C-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B635D-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B635F-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B635E-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B6360-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B6367-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B6369-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B636A-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B6366-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B6365-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B6368-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B6356-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B6363-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B6364-363D-11E5-9242-09173F13E4C5